½ÃÀ庸°í¼­
»óǰÄÚµå
1301674

ÀÇ·á ¿µ»ó¿ë ÀΰøÁö´É(AI) ½ÃÀå : ¾ç½Äº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ¼¼°è ¿¹Ãø(2023-2032³â)

Artificial Intelligence in Medical Imaging Market - By Technology, Clinical Application, Modalities, End-user, Global Forecast 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÀÇ·á ¿µ»ó¿ë AI ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö Å©°Ô È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á ¿µ»ó¿ë AI°¡ Á¦°øÇÏ´Â Áø´Ü Á¤È®µµ ¹× Ä¡·á °èȹÀÇ °³¼±Àº ¾÷°è ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, AI ¾Ë°í¸®ÁòÀº ´ë·®ÀÇ ÀÇ·á À̹ÌÁö¸¦ ½Å¼ÓÇÏ°Ô Ã³¸®ÇÏ°í ºÐ¼®ÇÏ¿© À̹ÌÁö ÇØ¼®¿¡ ÇÊ¿äÇÑ ½Ã°£À» Å©°Ô ´ÜÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â Áø´Ü °úÁ¤À» °¡¼ÓÈ­Çϰí ÀÇ·á Àü¹®°¡°¡ Àû½Ã¿¡ ÆÇ´ÜÀ» ³»¸®°í ÀûÀýÇÑ Ä¡·á °èȹÀ» ¼ö¸³ÇÒ ¼ö ÀÖµµ·Ï µµ¿Í ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÏ°Ô ÀÛ¿ëÇÕ´Ï´Ù.

ÀÇ·á ¿µ»ó¿ë AI ½ÃÀåÀº Àüü ÀÇ·á¿ë AI ½ÃÀåÀ» ¾ç½Ä, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°·Î ºÐ·ùÇÕ´Ï´Ù.

¾ç½Äº°·Î º¸¸é ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(CT) ºÎ¹®Àº 2022³â ¾÷°è ±Ô¸ð°¡ 2¾ï 6,100¸¸ ´Þ·¯ ÀÌ»ó¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, AI ±â¹Ý ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ À̹ÌÁöÀÇ Á¤È®µµ¿Í Á¤¹Ðµµ°¡ Çâ»óµÇ¸é¼­ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Ù, ÀÚµ¿ ÃøÁ¤, ÁÖ¼®, Á¤·®Àû µ¥ÀÌÅ͸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â Áø´Ü ¿öÅ©Ç÷ο츦 °¡¼ÓÈ­ÇÏ°í ¹æ»ç¼±°ú Àǻ簡 CT ½ºÄµÀ» º¸´Ù È¿À²ÀûÀ¸·Î °ËÅäÇϰí ÇØ¼®ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ¿© ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¿ëµµº°·Î º¸¸é Æó ¿µ»ó ºÎ¹®Àº 2023-2032³â µÎµå·¯Áø CAGR·Î ¾÷°è Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Æó ÁúȯÀÇ Á¶±â Áø´Ü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ AI ±â¹Ý ÀÇ·á ¿µ»ó ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, AI ¾Ë°í¸®ÁòÀº ÈäºÎ ¿¢½º·¹ÀÌ ¹× CT ½ºÄµ°ú °°Àº ÀÇ·á ¿µ»ó µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© Æó ÁúȯÀÇ Á¶±â ¡Èĸ¦ ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. AI ½Ã½ºÅÛÀº Æó ÁúȯÀ» ³ªÅ¸³»´Â ¹Ì¹¦ÇÑ ÀÌ»ó°ú ÆÐÅÏÀ» °¨ÁöÇÏ¿© Á¶±â Áø´ÜÀ» Áö¿øÇϰí, Àû½Ã¿¡ °³ÀÔÇϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÏ¿© Á¦Ç° äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚ¸¦ ±âÁØÀ¸·Î Áø´Ü¼¾ÅÍ ºÎ¹®ÀÇ »ê¾÷ °¡Ä¡´Â 2032³â±îÁö Å« ÀÌÀÍÀ» ¾òÀ» °ÍÀÔ´Ï´Ù. Áø´Ü¼¾ÅÍ¿¡¼­ °í±Þ AI ±â¹Ý ÀÇ·á¿ë Ä«¸Þ¶óÀÇ ³ôÀº °¡¿ë¼ºÀÌ ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ã·´Ü AI ±â¹Ý ¿µ»ó Áø´Ü ¾ç½Ä¿¡ ´ëÇÑ È¯ÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÏ»óÀûÀÎ Áø´Ü ÀýÂ÷¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ºÎ¹® ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. Áø´Ü¼¾ÅÍÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó AI ±â¹Ý ÀÇ·á ¿µ»ó ÃÔ¿µ ºóµµ°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î º¸¸é ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á ¿µ»ó¿ë AI ½ÃÀå Á¡À¯À²Àº 2023-2032³â 31% ÀÌ»óÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀÔ´Ï´Ù. IBEF¿¡ µû¸£¸é ÀεµÀÇ ÀÇ·á ±â¼ú »ê¾÷Àº 2030³â±îÁö 500¾ï ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ºü¸£°Ô È®ÀåµÇ´Â ÀÇ·á ÀÎÇÁ¶ó¿Í ÇÔ²² µðÁöÅÐÈ­ÀÇ ÁøÀüÀÌ ÀÌ Áö¿ªÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Æó¾ÏÀÇ ±Þ°ÝÇÑ Áõ°¡´Â Á¶±â Áø´ÜÀ» À§ÇÑ AI ±â¹Ý ÀÇ·á ¿µ»ó ÃÔ¿µ ±â¹ý¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÇ·á ¿µ»ó¿ë ÀΰøÁö´É(AI) »ê¾÷ ÀλçÀÌÆ®

  • ¿¡ÄڽýºÅÛ ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • AIÀÇ ±â¼úÀû Áøº¸¿¡ ÀÇÇØ ÀÇ·á ¿µ»ó¿¡ ´ëÇÑ ÀÀ¿ëÀÌ È®´ë
      • ¼¼°èÀÇ ¹æ»ç¼±°úÀÇ ºÎÁ·¿¡ ÀÇÇØ ÀÇ·á ¿µ»ó¿ë AIÀÇ µµÀÔÀÌ Áõ°¡
      • ÀÇ·á ¿µ»ó¿ë AI°¡ Á¦°øÇÏ´Â Áø´Ü Á¤µµ¿Í Ä¡·á °èȹÀÇ Çâ»ó
      • ½ÃÀå ±â¾÷ ¿¡ÄڽýºÅÛ È®´ë¿¡ ÀÇÇÑ ¸·´ëÇÑ ¿¬±¸°³¹ß ÅõÀÚ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
      • ±ÔÁ¦±â°ü ½ÂÀÎ ÇÁ·Î¼¼½ºÀÇ Áö¿¬
      • AI ¿¡·¯¿¡ ÀÇÇÑ È¯ÀÚ ÇÇÇØ
  • ¼ºÀå °¡´É¼º ºÐ¼®
    • ¸ð´Þ¸®Æ¼º°
    • ÀÀ¿ëº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • COVID-19 ¿µÇ⠺м®
  • ±ÔÁ¦ »óȲ
    • ¹Ì±¹
    • À¯·´
  • ÀÇ·á ¿µ»ó¿ë ±â°èÇнÀÀÌ ÃÊ·¡ÇÏ´Â ÀÌÁ¡
    • ȯÀÚ °ü¸®¿Í ½ºÄÉÁÙ¸µ
    • ¿µ»ó Ãëµæ
    • ¿µ»ó ÇØ¼®
    • ÀÇ·á ¿µ»ó ¸®Æ÷Æ®
    • Ä¡·á °èȹ°ú ÆÈ·Î¿ì ¾÷
  • ÀÇ·á ¿µ»ó¿ë AIÀÇ °úÁ¦
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ, 2022³â

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®, 2022³â
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå, 2022³â

Á¦5Àå ÀÇ·á ¿µ»ó¿ë ÀΰøÁö´É(AI) ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¸ð´Þ¸®Æ¼º°

  • ÁÖ¿ä µ¿Çâ : ¸ð´Þ¸®Æ¼º°
  • X¼±
  • ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT)
  • ÀÚ±â°ø¸í¿µ»ó ¹ý(MRI)
  • ÃÊÀ½ÆÄ À̹Ì¡
  • ºÐÀÚ À̹Ì¡

Á¦6Àå ÀÇ·á ¿µ»ó¿ë ÀΰøÁö´É(AI) ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÀÀ¿ëº°

  • ÁÖ¿ä µ¿Çâ : ÀÀ¿ëº°
  • À¯¹æ À̹Ì¡
  • Æó À̹Ì¡
  • ½Å°æ
  • ½ÉÇ÷°ü
  • °£ À̹Ì¡
  • ±âŸ ¿ëµµ

Á¦7Àå ÀÇ·á ¿µ»ó¿ë ÀΰøÁö´É(AI) ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • ÁÖ¿ä µ¿Çâ : ÃÖÁ¾»ç¿ëÀÚº°
  • º´¿ø
  • Áø·á¼Ò
  • Áø´Ü ¼¾ÅÍ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ÀÇ·á ¿µ»ó¿ë ÀΰøÁö´É(AI) ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä µ¿Çâ : Áö¿ªº°
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • Arterys Inc.
  • DIGITAL DIAGNOSTICS INC.
  • GE Healthcare
  • IBM Watson Health
  • InformAI, LLC
  • Intel Corporation
  • Koninklijke Philips N.V.
  • Lunit Inc.
  • Nanox Imaging LTD.
  • Siemens Healthcare GmbH
KSA 23.07.28

Global AI in Medical Imaging Market size will expand significantly through 2032. Improved diagnostic accuracy and treatment planning provided by AI in medical imaging are expected to generate lucrative opportunities for industry growth. AI algorithms can rapidly process and analyze large volumes of medical images, significantly reducing the time required for image interpretation. This expedites the diagnostic process, allowing healthcare professionals to make timely decisions and initiate appropriate treatment plans, favoring market growth.

The overall AI in medical imaging market is divided based on modality, application, end-use, and region.

Based on the modality, the industry size from the computed tomography (CT) segment reached over USD 261 million in 2022. Improved accuracy and precision of AI-based computed tomography images have increased their demand. AI algorithms can quickly analyze large volumes of CT images and provide automated measurements, annotations, and quantitative data. This expedites the diagnostic workflow, allowing radiologists to review and interpret CT scans more efficiently, supporting segment growth.

Based on the application, industry share from the lung imaging segment will grow at a notable CAGR from 2023 to 2032. Growing focus on early diagnosis of lung diseases has increased the demand for AI-based medical imaging systems. AI algorithms can analyze medical imaging data, such as chest X-rays or CT scans, to identify early signs of lung disorders. By detecting subtle abnormalities or patterns indicative of lung diseases, AI systems can aid in early diagnosis, allowing for timely interventions and improved patient outcomes, fostering product adoption.

Based on the end-use, industry value from the diagnostic centers segment will amass significant gains through 2032. High availability of advanced AI-based medical cameras in diagnostic centers is contributing to segment growth. Moreover, the growing demand for routine diagnostic procedures, in line with rising patient awareness about advanced AI-based imaging modalities, is further generating lucrative opportunities for segment growth. Growing number of diagnostic centers has further increased the frequency of AI-based medical image acquisitions.

From the regional standpoint, Asia Pacific AI in medical imaging market share will grow at over 31% CAGR from 2023 to 2032. Growing digitalization coupled with rapidly expanding healthcare infrastructure is contributing to regional growth. As per IBEF, India's MedTech industry has the potential to reach USD 50 billion by 2030. Surging prevalence of lung cancer has further bolstered the demand for AI-based medical imaging modalities in the region for early disease diagnosis.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Artificial intelligence in medical imaging market 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Modality trends
    • 2.1.4 Application trends
    • 2.1.5 End-use trends

Chapter 3 Artificial Intelligence in Medical Imaging Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancements in AI increase its applications in medical imaging
      • 3.2.1.2 Global shortage of radiologists will increase the adoption of AI in medical imaging
      • 3.2.1.3 Improved diagnostic accuracy and treatment planning offered by AI in medical imaging
      • 3.2.1.4 Huge R&D investment from growing ecosystem of market players
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Slow regulatory approval process
      • 3.2.2.2 Patient harm due to AI errors
  • 3.3 Growth potential analysis
    • 3.3.1 By modality
    • 3.3.2 By application
    • 3.3.3 By end-user
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Benefits offered by machine learning in medical imaging
    • 3.6.1 Patient management and scheduling
    • 3.6.2 Image acquisition
    • 3.6.3 Image analysis
    • 3.6.4 Medical image reporting
    • 3.6.5 Treatment planning & follow-up
  • 3.7 Challenges for AI in medical imaging
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Strategic outlook matrix
  • 4.5 Strategy dashboard, 2022

Chapter 5 Artificial Intelligence in Medical Imaging Market Size and Forecast, By Modality (USD Million)

  • 5.1 Key trends, by modality
  • 5.2 X-ray
  • 5.3 Computed tomography (CT)
  • 5.4 Magnetic Resonance Imaging (MRI)
  • 5.5 Ultrasound imaging
  • 5.6 Molecular imaging

Chapter 6 Artificial Intelligence in Medical Imaging Market Size and Forecast, By Application (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Breast imaging
  • 6.3 Lung imaging
  • 6.4 Neurology
  • 6.5 Cardiovascular applications
  • 6.6 Liver imaging
  • 6.7 Other applications

Chapter 7 Artificial Intelligence in Medical Imaging Market Size and Forecast, By End-use (USD Million)

  • 7.1 Key trends, by end-use
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Diagnostic centers
  • 7.5 Other end users

Chapter 8 Artificial Intelligence in Medical Imaging Market Size and Forecast, By Region (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Arterys Inc.
  • 9.2 DIGITAL DIAGNOSTICS INC.
  • 9.3 GE Healthcare
  • 9.4 IBM Watson Health
  • 9.5 InformAI, LLC
  • 9.6 Intel Corporation
  • 9.7 Koninklijke Philips N.V.
  • 9.8 Lunit Inc.
  • 9.9 Nanox Imaging LTD.
  • 9.10 Siemens Healthcare GmbH
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦